Day One Biopharmaceuticals, Inc.
Developing targeted cancer therapies for all ages, with a focus on pediatric oncology.
DAWN | NDAQ
Overview
Corporate Details
- ISIN(s):
- US23954D1090
- LEI:
- Country:
- United States of America
- Address:
- 1800 SIERRA POINT PARKWAY, SUITE 200, 94005 BRISBANE
- Website:
- https://dayonebio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Day One Biopharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing targeted therapies for cancer patients of all ages. The company aims to disrupt traditional drug development by accelerating the delivery of new medicines to both children and adults with life-threatening diseases. Utilizing a "search and development" strategy, Day One identifies and advances promising first- or best-in-class treatments to address unmet medical needs. Its portfolio is particularly noted for its work in pediatric oncology, including the development of therapies for conditions such as pediatric low-grade glioma (pLGG).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Day One Biopharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Day One Biopharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Day One Biopharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
